This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Effect of Testofen on Erectile Function in an Adult Male Population

Sponsored by RDC Clinical Pty Ltd

About this trial

Last updated 9 months ago

Study ID

TESTEF

Status

Recruiting

Type

Interventional

Phase

Phase 3

Placebo

No

Accepting

18-75 Years
40 to 75 Years
Male
Male

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 3 years ago

What is this trial about?

This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.

What are the participation requirements?

Yes

Inclusion Criteria

- Healthy male adults aged 40-75 years - Currently in a sexual relationship - Males with reduced erectile function (Score of <25 on IIEF) - BMI ≤ 35 - Able to provide informed consent - Agree not to change current diet and exercise program while enrolled in this trial - Agree not to undertake another clinical trial while enrolled in this trial

No

Exclusion Criteria

- History of prostate surgery and/or trauma - Receiving/prescribed treatment for erectile dysfunction, including oral medications, vacuum devices, constrictive devices, injections, or urethral suppositories - Receiving/prescribed treatment to increase/decrease testosterone levels e.g. androgens/anti androgens - Receiving/prescribed treatment to increase/decrease nitrate or nitric oxide levels - Unstable or serious illness (e.g. serious mood disorders, neurological disorders such as MS, kidney disease, liver disease, heart conditions, diabetes, hormone production disorders)* - All current malignancies (excluding BCC) or chemotherapy and/or radiotherapy treatment for malignancy within the previous 2 years - Receiving/prescribed [e.g., Coumadin or Marevan (warfarin), heparin, dalteparin, enoxaparin) or other anticoagulation therapy (e.g., thromboembolectomy or the use of vena cava filters) - Active smokers, nicotine use, alcohol, or drug (prescription or illegal substances) abuse - Chronic past and/or current alcohol use (>14 alcoholic drinks week) - Allergic to any of the ingredients in the active or placebo formula - Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion - Participants who have participated in any other related clinical study during the past 1 month a Any participant reporting having been told by their doctor that they have an under or over production of hormones (e.g., testosterone). *An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.

Locations

Location

Status

Recruiting